Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

prostate cancer PSA

Total-body PET scanner detects cancer in 60 seconds

The new equipment, which initially will be used to treat prostate and neuroendocrine tumors, is expected to be operational in July.

CT scan showing lung cancer nodules with measurements of each nodule to track growth or regression from treatment. Image courtesy of RSNA

American Indian/Alaskan Native tribes three times more likely to get lung or colorectal cancer

This week presenters at the annual ARRS meeting discussed barriers these populations face when trying access vital cancer screenings.

lung cancer

Lung cancer risk increases with emphysema severity

Researchers analyzed a total of 21 studies that included more than 107,000 patients who had undergone CT assessments to examine associations between emphysema and lung cancer.

neck ultrasound thyroid

DL networks augment radiologist performance for thyroid cancer detection

After being presented with more than 15,000 images, each DL network yielded results comparable to that of four seasoned radiologists, authors of a new EJR study said.

Stratifying patients by risk of poor outcomes could reduce overtreatment of lung cancer

Researchers are using radiomics to narrow patient cohorts down to those who are at the greatest risk of poor lung cancer outcomes.

Thumbnail

AI spots pancreatic cancer in its earliest stages

Experts involved in the study suggest their findings could eventually be used to detect pancreatic cancer in its earliest stages when patients are most likely to respond to interventions favorably.

breast radiologist breast cancer mammography

Metastatic breast cancer survival rates are up in Medicaid expansion states

A JAMA Oncology study found a decrease in two-year mortality rates between 2010 and 2015, attributing the findings to a 2014 Medicaid expansion.

Thumbnail

O-RADS externally validated for differentiating between benign and malignant ovarian lesions

In addition to O-RADS external validation, experts also sought to determine if incorporating acoustic shadowing as a benign finding would improve diagnostic performance.